YSK Labs Advantages of DC Granules

YSK Labs was featured on the CCD partners Watchlist 2023 aimed to highlight the profile of Innovative and disruptive Startup companies participating in the CPHI Startup Market 2023. This Watchlist is designed to capture and track exciting up-and-coming businesses with the potential to disrupt the pharmaceutical industry. 

Out of approximately 1000+ companies in over 57 countries, YSK Labs was amongst the 21 companies selected and featured. 

DC Granules Product List

Finished Formulations Product List

YSK Labs Company Brochure

We are extremely delighted to announce that YSK Laboratories Pvt Ltd was recently featured in the bespoke Watchlist 2023 by CCD Partners,

YSK Laboratories is a distinguished R&D company with an integrated manufacturing facility near Mumbai specializing in producing innovative pharmaceutical solutions, particularly our game-changing DC Granules. These Semi-Formulated APIs can be Directly Compressed into Solid Finished Dosage Forms (Tablets) in just ONE compression step. We take pride in offering Superior Quality: SUSTAINED RELEASE/EXTENDED RELEASE (SR/XR/ER) AND IMMEDIATE RELEASE (IR) PRODUCTS which stand out due to their unique Manufacturing Technologies and Lower Excipient Load. Our state-of-the-art production facilities stand as a testament to our unwavering commitment to quality. We maintain a capacity of 400-500 metric tons of DC Granules annually ensuring uninterrupted innovation, production and adherence to the highest industry standards and stringent norms including USFDA, EU GMP, UK MHRA, TGA & WHO GMP demonstrating our dedication to Quality and Regulatory Compliance.